| 2025-12-15 |
详情>>
内部人交易：
Ellenbogen Michael共交易2笔
|
| 2025-11-13 |
详情>>
股本变动：
变动后总股本17461.76万股
|
| 2025-11-13 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.26美元,归母净利润-4402万美元,同比去年增长-14.94%
|
| 2025-11-13 |
财报披露：
美东时间 2025-11-13 盘后发布财报
|
| 2025-08-14 |
详情>>
业绩披露：
2025年中报每股收益-0.26美元,归母净利润-4222.4万美元,同比去年增长-416.06%
|
| 2025-05-20 |
详情>>
业绩披露：
2025年一季报每股收益-0.01美元,归母净利润-168.9万美元,同比去年增长85.49%
|
| 2025-04-30 |
股东大会：
将于2025-06-20召开股东大会
会议内容 ▼▲
- 1.To elect Kevin Charlton, John Kedzierski, Kimberly Sheehy, and Bilal Zuberi as Class I Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified;
2.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers (the “Say-on-Pay Vote”);
3.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
4.To transact such other business as may properly come before the Annual Meeting or any continuation, postponement, or adjournment of the Annual Meeting.
|
| 2025-04-28 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.25美元,归母净利润-3829.7万美元,同比去年增长57.14%
|
| 2025-04-28 |
详情>>
业绩披露：
2024年年报每股收益-0.34美元,归母净利润-5401.7万美元,同比去年增长49.16%
|
| 2024-10-25 |
复牌提示：
2024-10-25 07:55:00 停牌，复牌日期 2024-10-25 08:30:00
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-0.05美元,归母净利润-818.2万美元,同比去年增长91.42%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-0.08美元,归母净利润-1164.4万美元,同比去年增长59.30%
|
| 2024-04-15 |
股东大会：
将于2024-05-31召开股东大会
会议内容 ▼▲
- 1.To elect Michael Ellenbogen, Peter George, and Rajan Naik as Class III Directors to serve until the 2027 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified;
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To approve an amendment to our Second Amended and Restated Certificate of Incorporation to provide for exculpation of officers from breaches of fiduciary duty to the fullest extent permitted by the General Corporation Law of the State of Delaware;
4.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers (the “Say-on-Pay Vote”);
5.To approve, on an advisory (non-binding) basis, the annual frequency of future Say-on-Pay Votes;
6.To transact such other business as may properly come before the Annual Meeting or any continuation, postponement, or adjournment of the Annual Meeting.
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益-0.71美元,归母净利润-1.06亿美元,同比去年增长-22.42%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.6美元,归母净利润-8936.4万美元,同比去年增长-53.81%
|
| 2023-08-10 |
详情>>
业绩披露：
2023年中报每股收益-0.65美元,归母净利润-9536.3万美元,同比去年增长-141.5%
|
| 2023-04-13 |
股东大会：
将于2023-05-30召开股东大会
会议内容 ▼▲
- 1.To elect Alan Cohen, Neil Glat, Merline Saintil, and Mark Sullivan as Class II Directors to serve until the 2026 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified;
2.To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To transact such other business as may properly come before the Annual Meeting or any continuation, postponement, or adjournment of the Annual Meeting.
|
| 2022-04-13 |
股东大会：
将于2022-05-26召开股东大会
会议内容 ▼▲
- 1.To elect Kevin Charlton, David Orfao and Bilal Zuberi as Class I Directors to serve until the 2025 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified;
2.To ratify the appointment of PricewaterhouseCoopers LLP (“PwC”) as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To transact such other business as may properly come before the Annual Meeting or any continuation, postponement, or adjournment of the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-28 |
股东大会：
将于2021-07-15召开股东大会
会议内容 ▼▲
- 1.To consider and vote upon a proposal to approve the transactions contemplated under the Merger Agreement, dated as of March 5, 2021, as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as amended, the “Merger Agreement”), by and among NHIC, NHIC Sub Inc., a Delaware corporation and wholly-owned subsidiary of NHIC (“Merger Sub”) and Evolv Technologies, Inc., a Delaware corporation (“Evolv”), (the “Business Combination”), a copy of which is attached to this proxy statement/prospectus as Annex A. This proposal is referred to as the “Business Combination Proposal” or “Proposal 1.”
2. To consider and vote upon a proposal to approve the Amended and Restated Certificate of Incorporation of NHIC, a copy of which is attached to this proxy statement/prospectus as Annex B (the “Amended Charter”) to, among other things, change NHIC’s name to “Evolv Technologies Holdings, Inc.,” amend certain provisions related to authorized capital stock, the required vote to amend the charter and bylaws, and director removal, and to divide the board of directors into three classes, with one class of directors being elected in each year and each class (except for those directors appointed to our first annual meeting of stockholders) serving a three-year term, in each case, to be effective upon the consummation of the Business Combination. This proposal is referred to as the “Charter Approval Proposal” or “Proposal 2.”
3.To consider and vote upon a proposal to approve the Evolv Technologies Holdings, Inc. 2021 Incentive Award Plan (the “Incentive Award Plan”), a copy of which is to be attached to this proxy statement/prospectus as Annex C, to be effective upon the consummation of the Business Combination. This proposal is referred to as the “Stock Plan Proposal” or “Proposal 3.”
4. To consider and vote upon a proposal to approve the Evolv Technologies Holdings, Inc. 2021 Employee Stock Purchase Plan (the “ESPP”), a copy of which is attached to this proxy statement/prospectus as Annex D, to be effective upon consummation of the Business Combination. This proposal is referred to as the “ESPP Proposal” or “Proposal 4.”
5.To consider and vote upon a proposal to approve: (i) for purposes of complying with Nasdaq Listing Rule 5635 (a) and (b), the issuance of more than 20% of the issued and outstanding shares of NHIC common stock and the resulting change in control in connection with the Merger, and (ii) for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of more than 20% of the common stock in connection with the PIPE Investment upon the consummation of the Business Combination. This proposal is referred to as the “Nasdaq Proposal” or “Proposal 5.”
6. To consider and vote upon a proposal to approve the adjournment of the Meeting by the chairman thereof to a later date, if necessary, under certain circumstances, including for the purpose of soliciting additional proxies in favor of the foregoing Proposals, in the event NHIC does not receive the requisite stockholder vote to approve the Proposals. This proposal is called the “Adjournment Proposal” or “Proposal 6.”
|